Financials

  • Market Capitalization 9.33 B
  • Employee 253
  • Founded 2015
  • CEO N/A
  • Website www.kymeratx.com
  • Headquarter Delaware, United States
  • FIGI BBG00SDHC8D1
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-23.27
Índice preço/fluxo de caixa
148.57

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
925
NUVL
Nuvalent, Inc. - Class A Common Stock
123.96 USD0.00%+0.18%+0.45%+30.55%9.79 B USD
939
CORT
Corcept Therapeutics Incorporated - Common Stock
88.90 USD-1.74%-3.53%+6.88%+21.17%9.54 B USD
971
IONS
Ionis Pharmaceuticals, Inc. - Common Stock
54.64 USD-0.53%-35.18%-26.09%-24.24%9.03 B USD
975
HALO
Halozyme Therapeutics, Inc. - Common Stock
75.92 USD+1.16%-3.83%+6.02%+13.65%9.01 B USD

Notícias